NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME
Download Read
Applicant
Ltd Shaanxi Huikang Bio-Tech Co.
Representative
Hruschka & Schnabel Habermann
Application number
EP18922817A1
Kind
A1
Document number
3834839
Shortcuts
→Abstract
→Claims

Classifications

NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME

3834839 - EP18922817A1 - EPO

Application Oct 30, 2018 - Publication Jun 16, 2021

Jin SHI Zengmiao HOU En GAO Xiaoying LI Xiaolin YANG Jinli ZHAO

Abstract

The present invention provides novel artificial tears containing a recombinant human lysozyme. The novel artificial tears comprise main components and an auxiliary material. The main components are a recombinant human lysozyme and a sodium hyaluronate, wherein the recombinant human lysozyme and the sodium hyaluronate are contained in an amount from 0.075%-0.300% and from 0.10%-0.30%, respectively in the total mass of the novel artificial tears. A drug for external use is prepared by combining the recombinant human lysozyme, the sodium hyaluronate and an excipient for treating light and moderate dry eye syndrome.

Description

Claims

Back to top

Statistics

Seen <100 times
Downloaded <100 times